ArticleNature communications2025
Data-driven protease engineering by DNA-recording and epistasis-aware machine learning.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Review
- The expanding role of protease therapeutics (2012-2026): from replacement therapies to immune system modulation and beyond.The Biochemical journal · 2026Review
- Identification and engineering of highly functional potyviral proteases in cells using co-evolutionary models.Nature communications · 2026Article
- Deep learning guided design of protease substrates.Nature communications · 2026Article
- Data-driven protease engineering by DNA-recording and epistasis-aware machine learning.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Protein engineering has recently seen tremendous transformation due to machine learning (ML) tools that predict structure from sequence at unprecedented precision. Predicting catalytic activity, however, remains challenging, restricting our capabilities to design protein sequences with desired catalytic function in silico. This predicament is mainly rooted in a lack of experimental methods capable of recording sequence-activity data in quantities sufficient for data-intensive ML techniques, and the inefficiency of searches in the enormous sequence spaces inherent to proteins. Herein, we address both limitations in the context of engineering proteases with tailored substrate specificity. We introduce a DNA recorder for deep specificity profiling of proteases in Escherichia coli as we demonstrate testing 29,716 candidate proteases against up to 134 substrates in parallel. The resulting sequence-activity data on approximately 600,000 protease-substrate pairs does not only reveal key sequence determinants governing protease specificity, but allows to build a data-efficient deep learning model that accurately predicts protease sequences with desired on- and off-target activities. Moreover, we present epistasis-aware training set design as a generalizable strategy to streamline searches within enormous sequence spaces, which strongly increases model accuracy at given experimental efforts and is thus likely to have implications for protein engineering far beyond proteases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.